Tempus AI, Inc (TEM)
After hours:
| Previous close | 51.31 |
| Open | 53.91 |
| Bid | 49.78 x 300 |
| Ask | 50.21 x 100 |
| Day's range | 49.90 - 54.61 |
| 52-week range | 22.89 - 77.00 |
| Volume | |
| Avg. volume | 1,145,400 |
| Market cap | 7.73B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Tempus Launches Beta Version of olivia, its AI-enabled Personal Health Concierge App for Patients
CHICAGO, September 12, 2024--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the beta launch of a patient-facing app, olivia, an AI-enabled personal health concierge to empower individuals to holistically organize, manage, and proactively take control of their own health data. olivia, which is currently only available to beta users, leverages generative AI to provide patients and their caregivers perso
- Business Wire
Tempus Announces Real World Data Collaboration with BioNTech
CHICAGO, September 04, 2024--Tempus AI, Inc. (NASDAQ: TEM, "Tempus"), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a multi-year collaboration with BioNTech SE (Nasdaq: BNTX, "BioNTech"), a global next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. This collaboration leverages Tempus' robust multimodal datasets in support of BioNTech’s next-generation oncology pipeline.
- Business Wire
Tempus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
CHICAGO, August 28, 2024--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4th, held in New York, NY.
